论文部分内容阅读
深圳诺普信2016上半年制剂销售额下降0.5%至1320.7百万元人民币(199.2百万美元),公司2015年销售额上升0.3%。净利润19.5百万元人民币(2.9百万美元),同比下降91.4%。制剂毛利率下降3.9个百分点。2016上半年最大的产品类别——杀虫剂销售额上升0.5%至574.9百万人民币(86.7百万美元),除草剂销售额下降20%至233.6百万元人民币(35.2百万美元),杀菌剂收入上升10.2%至503.1百万元人民币(75.9百万美元),作物
For the first half of 2016, Shenzhen Nuopus Pharmaceutical Manufacturing Sales decreased 0.5% to RMB1320.7 million (US $ 199.2 million). The Company’s sales in 2015 increased by 0.3%. Net profit of 19.5 million yuan (2.9 million US dollars), down 91.4%. Prepaid gross profit margin decreased 3.9 percentage points. Sales of pesticides increased 0.5% to RMB 574.9 million (US $ 86.7 million), while sales of herbicides decreased by 20% to RMB 233.6 million (US $ 35.2 million), the largest product category in the first half of 2016. Sterilization Revenue from pharmaceuticals increased 10.2% to 503.1 million yuan ($ 75.9 million) for crops